Abstract
We previously reported that the metabolism of cotinine, the proximate metabolite of nicotine, is significantly slower in black than in white cigarette smokers. To understand why the metabolism of nicotine and cotinine might differ between blacks and whites, we studied the pattern of nicotine metabolism in blacks and whites. One hundred eight healthy smokers (51 blacks and 57 whites), of similar age, gender distribution, and smoking history, received an i.v. infusion of deuterium-labeled nicotine and cotinine. The clearance of cotinine, the fractional conversion of nicotine to cotinine, and the metabolic clearance of nicotine to cotinine were significantly lower in blacks than in whites. Blacks excreted significantly less nicotine as nicotine-N-glucuronide and less cotinine as cotinine-N-glucuronide than whites, but there was no difference in the excretion of 3′-hydroxycotinine-O-glucuronide. Nicotine and cotinine glucuronidation appeared to be polymorphic, with evidence of slow and fast N-glucuronide formers among blacks but was unimodal with fast conjugators only among whites. Other findings of note included the demonstration of a significant correlation between the distribution volumes of nicotine and cotinine with lean body mass: there was a smaller distribution volume and a shorter half-life for cotinine in women than in men and a smaller volume of distribution of cotinine in blacks than in whites. We conclude that the metabolism of cotinine is slower in blacks than in whites because of both slower oxidative metabolism of nicotine to cotinine (presumably via cytochrome P-450 2A6) and slowerN-glucuronidation. Ethnic differences in the metabolism of other drugs undergoing N-glucuronidation should be studied.
Footnotes
-
Send reprint requests to: Neal L. Benowitz, M.D., Chief, Division of Clinical Pharmacology and Experimental Therapeutics, University of California, San Francisco, Box 1220, San Francisco, CA 94143-1220. E-mail:nbeno{at}itsa.ucsf.edu
-
↵1 This work was supported by State of California Tobacco-Related Disease Research Program Grant 1RT-0521, United States Public Health Service Grants DA02277 and DA01696 awarded by the National Institute on Drug Abuse, Grants CA39260 and CA32389 awarded by the National Cancer Institute, Grant HS07373 awarded by the Agency for Health Care Policy and Research, and Grant 1P30-AG15272 awarded by the National Institute on Aging, the National Institute of Nursing Research, and the Office of Research on Minority Health and carried out in part at the General Clinical Research Center at San Francisco General Hospital with support of the Division of Research Resources, National Institutes of Health (Grant RR00083). E.J.P.-S. was a Henry J. Kaiser Family Foundation Faculty Scholar in General Medicine during the completion of the study.
- Abbreviations:
- CL
- clearance
- AUC
- area under the plasma concentration-time curve
- CYP
- cytochrome P-450
- f
- fractional conversion of nicotine to cotinine
- Received April 27, 1999.
- Accepted August 2, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|